Loomis, Sayles & Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-18,480
| Closed | -$1.8M | – | 904 |
|
|
2018
Q4 | $1.8M | Sell |
18,480
-18,237
| -50% | -$1.78M | ﹤0.01% | 520 |
|
|
2018
Q3 | $5.1M | Sell |
36,717
-84,276
| -70% | -$11.7M | 0.01% | 475 |
|
|
2018
Q2 | $15M | Sell |
120,993
-58,299
| -33% | -$7.24M | 0.03% | 316 |
|
|
2018
Q1 | $20M | Sell |
179,292
-3,038
| -2% | -$339K | 0.04% | 247 |
|
|
2017
Q4 | $21.8M | Buy |
182,330
+64,275
| +54% | +$7.69M | 0.05% | 245 |
|
|
2017
Q3 | $16.6M | Sell |
118,055
-47,497
| -29% | -$6.66M | 0.04% | 320 |
|
|
2017
Q2 | $20.1M | Buy |
165,552
+83,549
| +102% | +$10.2M | 0.05% | 253 |
|
|
2017
Q1 | $9.94M | Sell |
82,003
-80,051
| -49% | -$9.71M | 0.02% | 419 |
|
|
2016
Q4 | $19.8M | Sell |
162,054
-33,280
| -17% | -$4.07M | 0.05% | 266 |
|
|
2016
Q3 | $23.9M | Sell |
195,334
-22,360
| -10% | -$2.74M | 0.06% | 209 |
|
|
2016
Q2 | $25.4M | Sell |
217,694
-374,785
| -63% | -$43.8M | 0.07% | 204 |
|
|
2016
Q1 | $82.5M | Buy |
592,479
+43,568
| +8% | +$6.07M | 0.23% | 60 |
|
|
2015
Q4 | $105M | Buy |
548,911
+59,344
| +12% | +$11.3M | 0.3% | 47 |
|
|
2015
Q3 | $76.6M | Buy |
489,567
+70,243
| +17% | +$11M | 0.23% | 69 |
|
|
2015
Q2 | $75.8M | Buy |
+419,324
| New | +$75.8M | 0.21% | 79 |
|
|
2014
Q1 | – | Sell |
-22,106
| Closed | -$2.94M | – | 785 |
|
|
2013
Q4 | $2.94M | Buy |
+22,106
| New | +$2.94M | 0.01% | 580 |
|